Amgen on Monday launched $1.5 billion of debt in a two-part sale. The offering includes $900 million of 10-year notes expected to yield 77 basis points over comparable U.S. treasuries and $600 million of 31-year bonds expected to yield 117 basis points more than U.S. treasuries.
The joint book managers on the sale are Citigroup, Goldman Sachs and Morgan Stanley.
Oxea is returning to its old name and its roots.
The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.
Novo Nordisk recently announced changes to its executive leadership and Board of Directors.
Valerie Diele-Braun resigned from her position as CEO and member of the Executive Board of IMCD at the end of April for personal reasons.
Honeywell will acquire Johnson Matthey's Catalyst Technologies business segment for €2.15 billion in an all-cash transaction.
